Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 37.94 M45.01 M — Research & development —— — Operating income 64.2 M110.62 M — Non-Operating Income, Total 15.26 M19.31 M — Interest expense, net of interest capitalized 895 K909 K — Non-Operating Income, excl. Interest Expenses 14.36 M18.41 M — Unusual income/expense —— — Pretax income 96.3 M147.01 M — Equity in earnings —— — Taxes 26.23 M36.02 M — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 70.07 M111 M — Discontinued operations —— — Net income 70.07 M111 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 70.07 M111 M — Basic earnings per share (Basic EPS) 1.050.89 — Diluted earnings per share (Diluted EPS) 0.560.79 — Average basic shares outstanding 66.77 M125.25 M — Diluted shares outstanding 66.77 M140.11 M — EBITDA 67.22 M113.75 M — EBIT 64.2 M110.62 M — Cost of revenue 32.1 M36.39 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 3.02 M3.13 M —